HROW
HarrowยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HROW Profile
Harrow, Inc.
An eyecare pharmaceutical company that developing innovative ophthalmic prescription therapies
1A Burton Hills Blvd., Suite 200, Nashville, Tennessee 37215
--
Harrow, Inc., formed in Delaware in January 2006 as Bywater Resources Corporation, is primarily involved in mineral development activities. On September 11, 2007, it was renamed Transdel Pharmaceuticals, and on December 13, 2018, it was renamed Harrow Health. The company is an ophthalmology-focused pharmaceutical company specializing in the development, production and sale of innovative medicines that provide unique competitive advantages and meet unmet needs in the market. They are committed to fulfilling the company's mission to deliver high-quality new medicines to physicians and patients at affordable prices.
